KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,821,000 | +104.8% | 21,252 | +18.3% | 0.00% | +50.0% |
| Q2 2017 | $1,866,000 | +63.0% | 17,964 | +23.2% | 0.00% | +100.0% |
| Q1 2017 | $1,145,000 | +88.6% | 14,578 | +8.0% | 0.00% | 0.0% |
| Q4 2016 | $607,000 | +18.8% | 13,498 | +47.2% | 0.00% | 0.0% |
| Q3 2016 | $511,000 | +13.6% | 9,172 | +1.7% | 0.00% | – |
| Q2 2016 | $450,000 | +26.8% | 9,023 | +16.2% | 0.00% | – |
| Q1 2016 | $355,000 | -14.3% | 7,762 | +17.1% | 0.00% | – |
| Q4 2015 | $414,000 | +17.3% | 6,628 | +5.0% | 0.00% | – |
| Q3 2015 | $353,000 | +24.3% | 6,315 | +40.2% | 0.00% | – |
| Q2 2015 | $284,000 | +238.1% | 4,503 | +219.6% | 0.00% | – |
| Q1 2015 | $84,000 | +6.3% | 1,409 | 0.0% | 0.00% | – |
| Q4 2014 | $79,000 | – | 1,409 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |